FIELD: medicine.
SUBSTANCE: invention refers to medicine, specifically to functional diagnostics. That is ensured by electric neuromyography (ENMG) and neurosonography (NSG) on 10–15th day of the disease. Facial nerve diameter is measured on both sides in mastoid process by high-frequency ultrasonic linear transducer. Following coefficients are calculated as a percentage: ENMG is ratio of patient's M-response amplitudes to healthy one, neuroimaging (NSG) – ratio of healthy nerve diameter to patient. With ENMG coefficient ≤21 % in combination with NSG coefficient ≤75 % predict an unfavorable recovery of facial nerve function.
EFFECT: method provides accurate prediction of facial nerve function recovery, which enables timely correction of the conducted neurometabolic therapy and reduced length of inpatient stay.
1 cl, 4 dwg, 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR EARLY PREDICTION OF OUTCOME OF FACIAL NERVE NEUROPATHY IN CHILDREN | 2023 |
|
RU2820017C1 |
| METHOD OF TREATMENT OF ACUTE VIRAL FACIAL NERVE NEUROPATHY | 2007 |
|
RU2348401C2 |
| METHOD TO TREAT NEUROPATHY OF FACIAL NERVE | 1996 |
|
RU2107484C1 |
| METHOD FOR PREDICTING THE OUTCOME OF CONSERVATIVE TREATMENT OF PATIENTS WITH ISOLATED IMPAIRMENT OF THE MAJOR MANDIRAL BRANCH OF THE FACIAL NERVE | 2022 |
|
RU2796263C1 |
| METHOD FOR TREATING PATIENTS FOR FACIAL NERVE NEUROPATHY AGGRAVATED WITH CONTRACTURES | 2002 |
|
RU2223799C1 |
| METHOD FOR SELECTING THE TACTICS OF TREATMENT OF PATIENTS WITH ISOLATED LESION OF THE BORDERAL MANIBORDIAL BRANCH OF THE FACIAL NERVE | 2022 |
|
RU2796246C1 |
| THERAPY OF PATIENTS SUFFERING FROM NEUROLOGIC EXACERBATIONS | 2008 |
|
RU2360710C1 |
| METHOD OF SELECTING THE TACTICS OF TREATMENT OF PATIENTS WITH ISOLATED LESION OF THE BORDERAL MANIBORDIAL BRANCH OF THE FACIAL NERVE | 2022 |
|
RU2796865C1 |
| METHOD AND DEVICE FOR TREATING INJURED PERIPHERAL NERVES | 2002 |
|
RU2213590C1 |
| METHOD FOR PREDICTING DIPHTHERITIC POLYNEUROPATHY PROGRESS IN CHILDREN | 1997 |
|
RU2141786C1 |
